FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials

Gut. 2024 Jul 11;73(8):1400-1402. doi: 10.1136/gutjnl-2023-331115.
No abstract available

Keywords: LIVER BIOPSY; META-ANALYSIS; NONALCOHOLIC STEATOHEPATITIS.

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Fibroblast Growth Factors* / therapeutic use
  • Humans
  • Liver Cirrhosis* / drug therapy
  • Meta-Analysis as Topic
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Randomized Controlled Trials as Topic*
  • Systematic Reviews as Topic

Substances

  • fibroblast growth factor 21
  • Fibroblast Growth Factors